Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

BiOasis Technologies Inc V.BTI

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  BIOAF

biOasis Technologies Inc is a biopharmaceutical company focused on the delivery of therapeutics across the blood-brain barrier and into the brain tissue. Its focus is to address unmet medical needs with its proprietary Transcend Platform.
Price: $1.18 | Change: +$0.03 | %Change: +2.61%
Volume: 9,400 | Day High/Low: 1.19/1.18 | 52 Week High/Low: 1.50/0.75
View modes: 
0 stars

Holding 20,000 shares now. Love the potential

Hoping strong results are announced soon  rate and reply
3 stars

The base of the mountain: The Next 12-18 months:

You can imagine what the next 12-18 months will bring based upon increasing evidence: We go from virtually no data on Transcendpep to: 1. Release of published data for: Herceptin, Lysosomal Storage...read more
2 stars

RE:medimmune

BTI has said that it plans to file an IND in 2016 for the Herceptin product. In the video a couple months ago BTI said they just had to do a few toxicology studies before it moves to human testing...read more
5 stars

medimmune

So say you had this drug in development and it looked promising but you could not figure out how to get it past some barrier - we'll call it the "BBB". And then you had an opportunity to conduct some...read more
1 star

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Quarterly Report

Ha ha that dose not suprise me  rate and reply
1 star

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Quarterly Report

Why is this not $1000 yet? I'm so totally confused.. LOL  rate and reply
3.5 stars

RE:RE:RE:RE:RE:RE:RE:RE:RE:Quarterly Report

Abbvie and  UCB are still listed in BTI's network on BTI's website. Earlier they were also said to be "happy" with Transcend. BTI's results with Transcendpep have been "remarkable" for Lysosomal...read more
3.5 stars

RE:RE:RE:RE:RE:RE:RE:RE:Quarterly Report

Another factor that wouldl enhance the liklihood of converting the access agreements is if Abbvie and UCB are the parties involved since they have already completed testing of the first-gen technology...read more
5 stars

Trying to understand

So we've got multiple testing agreements covering overhead. That reduces any urgency for a PP. We've heard Rob say that the money would be available to advance the herceptin program. Finally, we've...read more
3.5 stars

RE:RE:RE:RE:RE:RE:RE:Quarterly Report

Rob actually says, re TAAs, "we're actually seeing now revenue starting to flow from those agreements and that's covering the overhead of the company"  (04:14,  https://www.youtube.com/watch?v...read more
3 stars

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Quarterly Report

To nitpick: These are Technology Access Agreements, not Transfer agreements. Big difference!  rate and reply
2 stars

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Quarterly Report

I dont understand how the market can understand "TTA" styles of aggreements in regards to every other company that is or has been involved with them. but in regards to bioasis we continue to get the...read more
3.5 stars

RE:RE:RE:RE:RE:RE:RE:RE:RE:Quarterly Report

These Technology Transfer Agreements (TTAs) are often two-stage with safety and pharmacokinetics being the first stage and efficacy the second, with each stage providing revenue. The agreements, as I...read more
1 star

RE:RE:RE:RE:RE:RE:RE:RE:Quarterly Report

I am not so sure about being all CF positive...TAA unless it's a recurring payments, I thought these are one time paymen type of deal?  rate and reply
3.5 stars

RE:RE:RE:RE:RE:RE:RE:Quarterly Report

Yup, that's what it means, MineDigger, and why I say that unless biOasis has the need for a lot of money for a specific purpose like a costly study or trial, then we may have seen the last of equity...read more
3.5 stars

RE:RE:RE:RE:RE:RE:Quarterly Report

jd, About the cash burn and having now listened to the BWH video... Rob actually says, re TAAs, "we're actually seeing now revenue starting to flow from those agreements and that's covering the...read more
3.5 stars

When will results be announced

Love the potential. Stock price has been weak lately. Surprised it didn't get more of a bounce on the recent harvard news. I don't think many people know about this exciting company. Hopefully...read more
0 stars

RE:RE:RE:Video

You can search 'The Transcend Repot' at YouTube for the new video and archive.  rate and reply
0 stars

RE:RE:Video

Where can I access this video...the BTI WEBSITE?  rate and reply
3.5 stars

RE:today's topic

What substantive thing would you like to talk about today, drjekyl? Your "answers" to my deal questions certainly were not substantive. They were fluff. What big topic would you like to offer us more...read more